Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates

Last updated: April 3, 2025
Sponsor: Kaplan Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

White Cell Disorders

Neutropenia

Treatment

Cord blood

Clinical Study ID

NCT06908616
KMC-24-0090
KMC-24-0090
  • Ages 1-1
  • All Genders

Study Summary

This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be collected to correlate phenotype with absolute neutrophil count (ANC).

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025

  • Parental informed consent obtained

  • Umbilical cord blood available for routine testing

Exclusion

Exclusion Criteria:

  • None

Study Design

Total Participants: 1000
Treatment Group(s): 1
Primary Treatment: Cord blood
Phase:
Study Start date:
October 08, 2024
Estimated Completion Date:
December 31, 2027

Study Description

This is a prospective, observational cohort study designed to evaluate the prevalence of the Duffy null phenotype (Fya-/Fyb-) and its association with ethnic neutropenia in neonates born at Kaplan Medical Center in Israel. The Duffy null phenotype has been linked to lower peripheral neutrophil counts without increased infection risk in certain ethnic groups, a condition commonly referred to as benign ethnic neutropenia.

Cord blood samples will be collected from approximately 1,000 neonates during routine G6PD testing. An additional 3 mL will be obtained non-invasively from the umbilical cord after labour to determine the expression of Duffy antigens using serologic gel testing. Parental consent will be obtained, and information regarding ethnicity and family history of neutropenia will be collected.

Participants identified with the Duffy null phenotype will be followed through electronic health records to assess their neutrophil counts during routine blood screening at 9-12 months of age. The study will analyze associations between Duffy phenotype, neutropenia prevalence, and parental ethnic origin.

Findings may support improved diagnostic clarity around neonatal neutropenia and help reduce unnecessary interventions in otherwise healthy infants with genetically determined low neutrophil counts.

Connect with a study center

  • Kaplan Medical Center

    Rehovot, 7661041
    Israel

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.